Chemist Warehouse’s $8.8b merger could stifle competition, shut stores: ACCC

Australia’s competition watchdog has raised concerns that Chemist Warehouse’s planned merger with Sigma Healthcare into an $8.8 billion pharmacy titan will lessen competition on the retail and wholesale levels, hinder rivals from growing or expanding, and result in the closure of chemists.

in early December that Chemist Warehouse was planning to sell its shares on the Australian stock exchange through a reverse listing via Sigma, a pharmaceutical wholesaler and distributor, in a merger that would create an industry giant. “Following the acquisition, the merged company may be able to use insights from data obtained to target pharmacies that rival Chemist Warehouse or pre-empt and undermine them,” Ridgeway said.There are around 600 Chemist Warehouse outlets in Australia that are not directly owned by the head company, but pharmacist-owned franchise stores supplied by the brand. Sigma supports 340 pharmacies under its Amcal and Discount Drug Store brands.

대한민국 최근 뉴스, 대한민국 헤드 라인

Similar News:다른 뉴스 소스에서 수집한 이와 유사한 뉴스 기사를 읽을 수도 있습니다.

ACCC says proposed Chemist Warehouse merger with Sigma Healthcare raises 'competition concerns'The Australian Competition and Consumer Commission says a proposed merger between pharmacy retail giant Chemist Warehouse and Sigma Healthcare raises 'competition concerns' in the country's pharmacy sector.
출처: abcnews - 🏆 5. / 83 더 많은 것을 읽으십시오 »